ReSound OMNIA RIE vs Resound Vivia 9 60S microRIE

The ReSound OMNIA RIE is a premium prescription behind-the-ear hearing aid released in 2022, currently priced at $4,498. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 36 devices in the Prescription Hearing Aid category. This device shows a mixed performance profile in our testing. Its standout strength is speech clarity in quiet environments, scoring 3.7/5—a solid result that sits 0.42 points above the category average. Own-voice comfort also performs above average at 3.0/5, which may appeal to users concerned about how their own voice sounds while wearing hearing aids. However, the OMNIA RIE struggles significantly in challenging listening situations. Speech-in-noise performance scored just 1.0/5, falling 0.96 points below the category average—a notable limitation for users who frequently encounter noisy restaurants, gatherings, or other difficult acoustic environments. Feedback handling, while strong in absolute terms at 4.1/5, also trails the category average by 0.61 points. Music streaming delivers mixed results at 2.7/5, essentially matching the category average. The OMNIA RIE offers versatile connectivity with both iPhone and Android streaming, hands-free calling capability, and the flexibility of both rechargeable and disposable battery options. At its premium price point, however, several competitors in the same price range—including the Phonak Sphere Infinio and Oticon Intent—deliver substantially higher overall scores. This device may suit users who prioritize quiet conversation clarity and own-voice comfort over challenging noise performance.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.